Evidence map›Paper›PMID 40649313›Full record

ArticleMolecules (Basel, Switzerland)2025

Development of Melt-Castable Explosive: Targeted Synthesis of 3,5-Dinitro-4-Methylnitramino-1-Methylpyrazole and Functional Derivatization of Key Intermediates.

Elena Reinhardt, Lukas Bauer, Antonia H Stadler, Henrik R Wilke, Arthur Delage, Jörg Stierstorfer, Thomas M Klapötke

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elena ReinhardtDepartment of Chemistry, Ludwig-Maximilians-University of Munich, Butenandtstr. 5-13, 81377 Munich, Germany.ORCID 0009-0009-9368-0829
Lukas BauerDepartment of Chemistry, Ludwig-Maximilians-University of Munich, Butenandtstr. 5-13, 81377 Munich, Germany.
Antonia H StadlerDepartment of Chemistry, Ludwig-Maximilians-University of Munich, Butenandtstr. 5-13, 81377 Munich, Germany.
Henrik R WilkeDepartment of Chemistry, Ludwig-Maximilians-University of Munich, Butenandtstr. 5-13, 81377 Munich, Germany.
Arthur DelageEurenco, 84700 Sorgues, France.
Jörg StierstorferDepartment of Chemistry, Ludwig-Maximilians-University of Munich, Butenandtstr. 5-13, 81377 Munich, Germany.ORCID 0000-0002-2105-1275
Thomas M KlapötkeDepartment of Chemistry, Ludwig-Maximilians-University of Munich, Butenandtstr. 5-13, 81377 Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The problems associated with TNT necessitate the development of novel melt-castable compounds with melting points between 70 and 120 °C, a crucial endeavor in the field of energetic materials. This study introduces a promising melt-castable explosive based on nitropyrazole, whose melt-castable properties were achieved by the introduction of methyl groups. The synthesis of 3,5-dinitro-4-methylnitramino-1-methylpyrazole involves a three-step process starting from 3,5-dinitro-4-chloropyrazole, including substitution, nitration, and methylation reactions. Additionally, two alternative synthesis routes and six energetic salts were examined. Structural elucidation was conducted using conventional methods such as NMR, IR, and X-ray, while the energetic properties of the compound, including thermal behavior, sensitivities, and theoretical performance, were investigated. Also, compatibility with common explosives was investigated, the experimental enthalpy of formation by bomb calorimetry was determined, and an SSRT test was performed. Furthermore, the melt-cast explosive underwent an Ames test in order to assess its toxicity.

Indexed as

bomb calorimetrycompatibilitymelt-castable explosivespyrazoleSSRTtoxicity

Identifiers

PMID40649313
PMCPMC12251357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.